New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them.

Abstract

Compound of formula (I): wherein: m and n represent 1 or 2, A represents a pyrrolyl group, X represents a C(O), S(O) or SO2 group, and R2 represent an alkyl group or, together with the nitrogen atom carrying them, form a heterocyclic group, R3 and R4, together with the atoms carrying them, form a heterocyclic group, Rs represents a hydrogen atom or an alkyl group, Rg represents a hydrogen atom or a halogen atom, and a pharmaceutical composition comprising thereof.